Targeted, Tailored and Timely (T3) Symptom Management for Prostate Cancer
针对前列腺癌的针对性、定制性和及时 (T3) 症状管理
基本信息
- 批准号:7259296
- 负责人:
- 金额:$ 18.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptedAdverse effectsAftercareAgeAndrogensAnxietyArizonaBehavioral ResearchCancer ControlCancer SurvivorCaringChronicCitiesClassificationClinical TrialsCommunitiesComputersConsentCounselingDataData CollectionDiagnosisDiarrheaDisruptionDistressDysuriaEducational MaterialsEducational process of instructingElderlyEmotionalEnsureExploratory/Developmental GrantFatigueFecal IncontinenceGoalsGrantHot flushesInflammationInternetInterventionIntestinesKnowledgeLearningLifeLocalizedMailsMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMenopausal hot flushesMental DepressionMethodsModelingNumbersOncologic NursingOncology NurseOutcomePainParticipantPatient PreferencesPatientsPilot ProjectsProstateProstate Cancer therapyProviderQuality of lifeRadiation therapyRandomized Clinical TrialsRecruitment ActivityReportingResearchResourcesRuralRural CommunitySamplingSelf CareSiteSleepSleep disturbancesSleeplessnessStructureSubgroupSurvivorsSymptomsTarget PopulationsTeaching MethodTelephoneTestingTimeTransportationUnderserved PopulationUtahWorkWritingbasecohortconceptdeprivationdesigndesireeligible participantexperiencehealth related quality of lifeimprovedinnovationmanmennovelolder menpreferenceprogramsresponserural areasizesocial cognitive theorysoundsymposiumsymptom managementtheoriesurinary
项目摘要
DESCRIPTION (provided by applicant): This exploratory study addresses the lack of systematic and structured symptom management targeted to men receiving radiation therapy ( androgen deprivation therapy) for prostate cancer. Because there is not a systematic and regular assessment of symptoms, they may go undetected. Patients may not report problems due to embarrassment, perceived busyness of providers, or lack of recognition that interventions are available to help. There is a lack of systematic educational programs to teach patients the self-care strategies that they can employ to manage their symptoms. As treatment ends, access to symptom management dwindles at the time when it is needed the most. This lack of access is compounded for older men who may have limited transportation and for those who reside in small towns or rural communities where resources are lacking. The long term goal of this research is to develop the most effective ways of improving quality of life for the increasing number of cancer survivors. The overall aims of this pilot study are (1) to test the feasibility and (2) to establish the initial efficacy and estimate the effect size of providing a systematic, structured, evidence- based symptom management intervention for older adult men with prostate cancer. T3 symptom management is an innovative approach which is targeted to the symptoms experienced by men with prostate cancer, tailored to the man's preferred learning method, and timed to when the symptoms are most likely to occur. The "T3" intervention provides a model to reach older adult prostate survivors, including men from rural communities, as they are completing radiation therapy. The targeted symptoms fatigue, insomnia, pain, urinary and bowel problems, hot flashes, depression and anxiety, This pilot study is an exploratory clinical trial which uses an experimental "patient preference" design with repeated measures in which two study groups will be compared in a 2:1 ratio: (1) the T3 symptom management intervention in which patients choose one of three preferred learning methods (n=72) or (2) usual care (n=36). One hundred and eight men (age 60 and older) who are completing radiation therapy ( androgen deprivation therapy) for prostate cancer and experiencing either a moderate level of symptom distress will be recruited to participate in the study from 2 settings in Utah and Arizona. It is anticipated that 40% of the participants (n=43) will reside in rural communities. All intervention and data collection methods will be delivered via computer (self-directed group only), mail, or telephone thus making them accessible to both rural and urban men with prostate cancer. One in 6 men will develop prostate cancer. This exploratory study addresses the lack of systematic and structured symptom management targeted to men receiving radiation therapy ( androgen deprivation therapy) for prostate cancer. Because there is not a systematic and regular assessment of symptoms, they may go undetected. Patients may not report problems due to embarrassment, perceived busyness of providers, or lack of recognition that interventions are available to help. This program can contribute to increasing knowledge about how to improve quality of life for men with prostate cancer by testing an innovative approach that targets troublesome symptoms and allows men to choose how they want to learn.
描述(由申请方提供):这项探索性研究旨在解决接受放射治疗(雄激素剥夺治疗)的前列腺癌男性缺乏系统和结构化症状管理的问题。由于没有对症状进行系统和定期的评估,它们可能无法被发现。患者可能不会报告问题,因为尴尬,感知供应商的忙碌,或缺乏对干预措施的认识。缺乏系统的教育计划来教导患者可以用来管理症状的自我护理策略。随着治疗的结束,在最需要的时候获得症状管理的机会就会减少。老年男子的交通工具可能有限,而居住在资源匮乏的小城镇或农村社区的老年人则更难获得这些服务。这项研究的长期目标是为越来越多的癌症幸存者开发提高生活质量的最有效方法。这项试点研究的总体目的是(1)测试可行性和(2)确定初步疗效,并估计为老年男性前列腺癌患者提供系统的、结构化的、循证的症状管理干预的效应量。T3症状管理是一种创新的方法,针对前列腺癌男性所经历的症状,根据男性首选的学习方法量身定制,并定时到症状最有可能发生的时间。“T3”干预提供了一个模式,以达到老年人前列腺幸存者,包括来自农村社区的男子,因为他们正在完成放射治疗。目标症状疲劳、失眠、疼痛、泌尿和肠道问题、潮热、抑郁和焦虑,该初步研究是一项探索性临床试验,其使用实验性“患者偏好”设计,重复测量,其中两个研究组将以2:1的比例进行比较:(1)T3症状管理干预,患者选择三种首选学习方法之一(n=72)或(2)常规护理(n=36)。将从犹他州和亚利桑那州的2个研究中心招募108名正在完成前列腺癌放疗(雄激素剥夺治疗)并经历中度症状困扰的男性(60岁及以上)参与研究。预计40%的参与者(n=43)将居住在农村社区。所有干预和数据收集方法将通过计算机(仅限自我指导小组)、邮件或电话提供,从而使农村和城市前列腺癌患者都能使用。六分之一的男性会患上前列腺癌。这项探索性研究解决了缺乏系统和结构化的症状管理,针对男性接受放射治疗(雄激素剥夺治疗)的前列腺癌。由于没有对症状进行系统和定期的评估,它们可能无法被发现。患者可能不会报告问题,因为尴尬,感知供应商的忙碌,或缺乏对干预措施的认识。该计划可以通过测试一种针对棘手症状的创新方法,并允许男性选择他们想要学习的方式,从而有助于增加有关如何提高前列腺癌男性生活质量的知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN L BECK其他文献
SUSAN L BECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN L BECK', 18)}}的其他基金
A New Multi-functional and Connected Mobile App Guiding Acupressure Use for Self-management and Monitoring of Cancer Related Fatigue and Sleep Disturbances
一款新的多功能互联移动应用程序,指导使用穴位按摩进行自我管理和监测癌症相关的疲劳和睡眠障碍
- 批准号:
10255903 - 财政年份:2021
- 资助金额:
$ 18.6万 - 项目类别:
Interdisciplinary Training in Cancer, Aging and End-of-Life Care
癌症、衰老和临终关怀的跨学科培训
- 批准号:
8473478 - 财政年份:2013
- 资助金额:
$ 18.6万 - 项目类别:
Interdisciplinary Training in Cancer, Aging and End-of-Life Care
癌症、衰老和临终关怀的跨学科培训
- 批准号:
8660350 - 财政年份:2013
- 资助金额:
$ 18.6万 - 项目类别:
Targeted, Tailored and Timely (T3) Symptom Management for Prostate Cancer
针对前列腺癌的针对性、定制性和及时 (T3) 症状管理
- 批准号:
7433343 - 财政年份:2007
- 资助金额:
$ 18.6万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Fellowship Programs














{{item.name}}会员




